Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Expert Review of Molecular Diagnostics|October 20, 2018
miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancersKonstantina Panoutsopoulou, Margaritis Avgeris, Andreas Scorilas
Expert Review of Molecular Diagnostics|October 10, 2019
Circulating exosomal miRNAs: clinical significance in human cancersMargaritis Avgeris, Konstantina Panoutsopoulou, Maria-Alexandra Papadimitriou, et al.
Wiley Interdisciplinary Reviews. RNA|May 17, 2022
Epi-miRNAs: Modern mediators of methylation status in human cancersMaria-Alexandra Papadimitriou, Konstantina Panoutsopoulou, Katerina-Marina Pilala, et al.
Journal of Cardiovascular Pharmacology|July 6, 2017
Combined Treatment With Exenatide and Cyclosporine A or Parstatin 1-26 Results in Enhanced Reduction of Infarct Size in a Rabbit ModelPanagiotis Alexopoulos, Konstantina Panoutsopoulou, George Vogiatzis, et al.
Clinical Biochemistry|December 12, 2022
Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancerKonstantina Panoutsopoulou, Yueyang Liu, Margaritis Avgeris, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 11, 2024
Exploring the methyl-verse: Dynamic interplay of epigenome and m6A epitranscriptomeKaterina-Marina Pilala, Konstantina Panoutsopoulou, Maria-Alexandra Papadimitriou, et al.
Trends in Molecular Medicine|July 29, 2023
Cancer quiescence: non-coding RNAs in the spotlightKonstantinos Soureas, Maria-Alexandra Papadimitriou, Konstantina Panoutsopoulou, et al.
Carcinogenesis|March 1, 2019
Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancerMargaritis Avgeris, Anastasia Tsilimantou, Panagiotis K Levis, et al.
Molecular Therapy. Nucleic Acids|November 2, 2022
Epigenetic regulation of MIR145 core promoter controls miR-143/145 cluster in bladder cancer progression and treatment outcomeKaterina-Marina Pilala, Maria-Alexandra Papadimitriou, Konstantina Panoutsopoulou, et al.
Cancers|January 11, 2022
tRNAGlyGCC-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and ProgressionKonstantina Panoutsopoulou, Tobias Dreyer, Julia Dorn, et al.
Pageof 2